Gregory Fraser
Stock Analyst at Truist Securities
(3.51)
# 330
Out of 5,370 analysts
40
Total ratings
64.29%
Success rate
69.70%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ANIP ANI Pharmaceuticals | Maintains: Hold | 62 65 | 64.9 | 0.15% | 9 | Apr 21, 2025 | |
JAZZ Jazz Pharmaceuticals | Maintains: Strong Buy | 220 230 | 108.53 | 111.92% | 1 | Mar 6, 2025 | |
BHC Bausch Health Compan... | Maintains: Hold | 8 7 | 5.91 | 18.44% | 2 | Jul 25, 2024 | |
XAIR Beyond Air | Maintains: Buy | 10 8 | n/a | n/a | 6 | Apr 30, 2024 | |
BTMD Biote | Maintains: Buy | 10 9 | 3.95 | 127.85% | 2 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 7 | 8.02 | -12.72% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 26 29 | 70.51 | -58.87% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 95 | 17.9 | 430.73% | 3 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 14 18 | 9.41 | 91.29% | 2 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 45 40 | 13.1 | 205.34% | 2 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 3 | n/a | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 7 6 | n/a | n/a | 1 | Apr 14, 2022 |